Initial report clears Parexel
Probe of injuries during tests hints problem was drug
Investigators in Britain have ruled out contamination, overdose, and procedural problems in the case of an experimental biotechnology drug that sent six patients to the intensive care unit of a London hospital last month. (Full article: 530 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
